Skip to main content

GOLDMAN SACHS GROUP INC

Position in TSHA — Taysha Gene Therapies, Inc.

CIK 886982 NEW YORK, NY

Position in TSHA

as of Mar 31, 2026 · filed May 15, 2026
Position Value
$99,992,312
+$24,682,248 QoQ
Shares Held
22,369,645
+63.4% QoQ
Ownership
7.78%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Sep 2020
18 quarters on record
Voting authority Sole 60.611788877293314.ToString("F0")% Shared 0.ToString("F0")% None 39.388211122706686.ToString("F0")%

Common Shares in TSHA Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Mar 31, 2026

GOLDMAN SACHS GROUP INC holds $10,294,260,512 across 365 Biotechnology names. TSHA ranks #25 (1.0% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in TSHA

Export CSV
19 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $99,992,312 22,369,645
2025-12-31 $75,310,064 13,692,739
2025-09-30 $43,764,724 13,383,708
2025-06-30 $29,077,586 12,587,700
2025-06-26 $30,725,012 12,748,968
2025-03-31 $499,019 359,007
2024-12-31 $1,673,158 967,144
2024-09-30 $2,423,398 1,205,671
2024-06-30 $2,300,518 1,027,018
2024-03-31 $3,039,220 1,058,962
2023-12-31 $147,748 83,474
2022-12-31 $27,407 12,127
2022-09-30 $83,921 43,483
2022-06-30 $257,717 69,279
2022-03-31 $580,533 89,039
2021-12-31 $618,008 53,048
2021-09-30 $225,283 12,099
2020-12-31 $391,810 14,763
2020-09-30 $1,761,200 78,625